Pancreatic Cancer Genetic Epidemiology (PACGENE) Study
NCT00526578 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4770
Last updated 2020-01-06
Summary
The goal of this research study is to investigate the role of genes that may point to a higher risk of developing pancreatic cancer.
Conditions
Interventions
- BEHAVIORAL
-
Questionnaire
Questionnaire taking about 30-40 minutes to complete.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Carrie Daniel-MacDougall, PHD · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-06-19
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
Countries
- United States
Study Locations
More Related Trials
-
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761 ·Status: RECRUITING
-
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer
NCT02560818 ·Status: COMPLETED ·Phase: NA
-
Genetic Investigation of Cancer Predisposition
NCT04620278 ·Status: NOT_YET_RECRUITING
-
Oncologist-Initiated Cancer Genetic Testing for Pancreatic Cancer Patients
NCT04316507 ·Status: UNKNOWN ·Phase: NA
-
Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico
NCT05305001 ·Status: COMPLETED
-
GENetic Education Risk Assessment and TEsting Study
NCT03762590 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pancreatic Cancer Genetics
NCT01102569 ·Status: RECRUITING
-
Clinical Outcomes in Hereditary Cancer
NCT00580021 ·Status: WITHDRAWN
-
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer
NCT02790944 ·Status: COMPLETED
-
Clinical and Laboratory Analysis of Familial Cancer
NCT02565004 ·Status: COMPLETED
-
Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients
NCT02706652 ·Status: TERMINATED
-
Validation of a Mouse Model of Pancreatic Carcinogenesis
NCT01103128 ·Status: TERMINATED
-
Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer
NCT05400681 ·Status: UNKNOWN
-
Genetic Testing Decision Aid
NCT05470920 ·Status: RECRUITING ·Phase: NA
-
Familial Investigations of Childhood Cancer Predisposition
NCT03050268 ·Status: RECRUITING
-
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00757614 ·Status: UNKNOWN
-
Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma
NCT03414827 ·Status: RECRUITING
-
A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors
NCT00745381 ·Status: COMPLETED
-
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
NCT00579163 ·Status: ACTIVE_NOT_RECRUITING
-
Collection of Blood From Patients With Prostate Cancer
NCT00923221 ·Status: RECRUITING
-
Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer
NCT05379907 ·Status: WITHDRAWN
-
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
NCT00001163 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Genetics Branch Eligibility Screening Survey
NCT07005297 ·Status: NOT_YET_RECRUITING
-
Molecular Genetics Studies of Cancer Patients and Their Relatives
NCT04185935 ·Status: RECRUITING
-
Understanding Genetic Incidental Findings in Your Family (UNIFY Study)
NCT02560896 ·Status: COMPLETED